From: Antimicrobial susceptibility testing results from 13 hospitals in Viet Nam: VINARES 2016–2017
Bacteria | All specimens | Blood and CSF (stool for Salmonella spp. and Shigella spp.) | |||||
---|---|---|---|---|---|---|---|
2012 (16 hospitals) | 2012 (13 hospitals) | 2016 | 2012 (16 hospitals) | 2012 (13 hospitals) | 2016 | ||
ESBL | E. coli | 1337/1928 (69%) | 626/844 (74%) | 4085/6953 (59%) | 126/183 (69%) | 59/81 (73%) | 655/1107 (59%) |
Imipenem | E. coli | 180/2 977 (6%) | 145/2111 (7%) | 687/8438 (8%) | 15/403 (4%) | 9/309 (3%) | 92/1410 (7%) |
Ceftriaxone | E. coli | 2342/4 192 (56%) | 776/1472 (53%) | 5051/7049 (72%) | 240/514 (47%) | 114/234 (49%) | 912/1324 (69%) |
MDR | E. coli | 453/1828 (25%) | 441/1639 (27%) | 2015/6956 (29%) | 24/125 (19%) | 24/125 (19%) | 336/1204 (28%) |
XDR | E. coli | 71/1828 (4%) | 63/1639 (4%) | 514/6956 (7%) | 2/125 (2%) | 2/125 (2%) | 65/1204 (5%) |
ESBL | K. pneumoniae | 887/1400 (63%) | 555/815 (68%) | 1186/2958 (40%) | 91/172 (53%) | 34/61 (56%) | 128/365 (35%) |
Imipenem | K. pneumoniae | 393/2 294 (17%) | 259/1697 (15%) | 891/3647 (24%) | 64/361 (18%) | 26/233 (11%) | 91/454 (20%) |
Ceftriaxone | K. pneumoniae | 1479/2 227 (66%) | 626/1380 (45%) | 1912/3436 (56%) | 101/190 (53%) | 63/175 (36%) | 214/435 (49%) |
MDR | K. pneumoniae | 318/1553 (20%) | 294/1315 (22%) | 428/3141 (14%) | 17/112 (15%) | 17/112 (15%) | 53/403 (13%) |
XDR | K. pneumoniae | 205/1553 (13%) | 171/1315 (13%) | 722/3141 (23%) | 12/112 (11%) | 12/112 (11%) | 81/403 (20%) |
Imipenem | A. baumannii | 1495/2138 (70%) | 1056/1584 (67%) | 2769/3551 (78%) | 110/244 (45%) | 85/205 (41%) | 100/178 (56%) |
MDR | A. baumannii | 897/1334 (67%) | 897/1282 (70%) | 2781/3442 (81%) | 27/44 (61%) | 27/44 (61%) | 101/171 (59%) |
Imipenem | P. aeruginosa | 578/1 765 (33%) | 322/996 (32%) | 1403/3220 (44%) | 36/129 (28%) | 22/88 (25%) | 49/135 (36%) |
MDR | P. aeruginosa | 178/576 (31%) | 144/392 (37%) | 660/1566 (42%) | 4/25 (16%) | 4/17 (24%) | 17/70 (24%) |
MRSA | S. aureus | 1 098/1 580 (69%) | 950/1303 (73%) | 3302/4515 (73%) | 145/197 (74%) | 130/171 (76%) | 476/674 (71%) |
Vancomycin* | S. aureus | 28/823 (3.4%) | 10/372 (2%) | 45/2680 (2%) | 5/135 (3.7%) | 0/65 (0%) | 7/565 (1%) |
Penicillin | S. pneumoniae | 115/344 (33%)** | 115/341 (34%)** | 663/1136(58%) | 7/30 (23%) ** | 7/30 (23%) ** | 42/114 (37%) |
Ceftriaxone | S. pneumoniae | 90/358 (25%) | 31/299 (10.4%) | 57/352 (16%) | 9/52 (17%) | 4/47 (8.5%) | 17/125 (14%) |
Vancomycin | E. faecium | 20/79 (25%) | 20/79 (25%) | 91/290 (31%) | 2/14 (14%) | 2/14 (14%) | 13/51 (25%) |
Ampicillin | H. influenzae | 160/226 (71%) | 1/1 (100%) | 804/911 (88%) | 3/5 (60%) | 1/1 (100%) | 7/8 (88%) |